Here are relevant reports on : age-verification-market
-
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
The global continuous renal replacement therapy market, valued at US$1.3 billion in 2022, stood at US$1.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and rising incidences of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to accelerate the growth of the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Nailing Systems Market by Product (Femoral Intramedullary Nails, Tibial Intramedullary Nail), Indication (Tibial fracture, humeral fracture), Material , Age Group, End User (Hospitals & Ambulatory Surgical Centers) & Region - Global Forecast to 2029
The global nailing systems market, valued at US$407.7 million in 2023, stood at US$427.7 million in 2024 and is projected to advance at a resilient CAGR of 5.3% from 2024 to 2029, culminating in a forecasted valuation of US$553.2 million by the end of the period. Market growth can be attributed to factors such as the rising prevalence of orthopedic disorders, the rising number of sports injuries, and increasing research funding and awareness initiatives.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting & Region - Global Forecast to 2029
The global mental health screening market, valued at US$0.8 billion in 2022, stood at US$0.9 billion in 2023 and is projected to advance at a resilient CAGR of 12.2% from 2023 to 2029, culminating in a forecasted valuation of US$1.8 billion by the end of the period. The growth of this market is driven by the rising awareness of mental health issues, growing geriatric population and subsequent increase in the prevalence of mental disorders, and technological advancements.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Enteral Feeding Devices Market By Type (Enteral Feeding Tubes, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding Tubes), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Global Forecast to 2032
The global enteral feeding devices market, valued at US$3.12 billion in 2024, stood at US$3.27 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2032, culminating in a forecasted valuation of US$4.76 billion by the end of the period. Market growth is driven by the increasing geriatric population, technological advancements, regulatory support, greater awareness of nutritional needs, and expansion in emerging economies.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Latin America Enteral Feeding Devices Market by Type (Enteral Feeding, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The Latin America Enteral Feeding Devices market, valued at USD 0.24 billion in 2025, stood at USD 0.25 billion in 2026 and is projected to advance at a resilient CAGR of 5.2% from 2026 to 2032, culminating in a forecasted valuation of USD 0.34 billion by the end of the period. The increase in the market is due to the growing cases of chronic and acute diseases that are difficult to manage without long-term nutritional support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
The global age-related macular degeneration (AMD) drugs market, valued at US$9.55 billion in 2023, stood at US$10.46 billion in 2024 and is projected to advance at a resilient CAGR of 10.7% from 2024 to 2029, culminating in a forecasted valuation of US$17.37 billion by the end of the period. Factors such as the increase in the prevalence of AMD cases due to the changing lifestyle and dietary habits such as smoking, alcohol consumption, and lack of physical activity, a growing focus on research and development highlighted by steady development and approvals of AMD drugs along with improvements in reimbursement policies providing better and affordable access to therapeutic AMD drugs, supports the growth of this market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Europe Enteral Feeding Devices Market by Type [Tubes(Nasal, Gastrostomy), Pumps {Portable, Stationary}, Enteral Syringe, Administration Set, Consumable], Insertion Method, Age Group (Neonate, Pediatric, Geriatric), Application, End user- Forecast to 2032
The Europe enteral feeding device market, valued at USD 0.85 billion in 2025, stood at USD 0.88 billion in 2026 and is projected to advance at a resilient CAGR of 4.0% from 2026 to 2032, culminating in a forecasted valuation of USD 1.11 billion by the end of the period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Plant-based Supplements Market by Product Type (Protein, Vitamins & Minerals, Superfood & Functional, Prebiotics & Probiotics, Ready-to-Drink (RTD), Snacks), Supplement Form, Age Group, End-use, Distribution Channel, and Region - Global Forecast to 2030
The plant-based supplements market is estimated at USD 27.52 billion in 2025 and is projected to reach USD 42.27 billion by 2030, at a CAGR of 9.0% during the forecast period. The report profiles key players such as Nestle (Switzerland), Abbott (US), Glanbia PLC (Germany), Otsuka Holdings Co., Ltd. (Japan), Herbalife Ltd. (US), H&H Group (China), Jamieson Wellness Inc. (Canada), NOW Foods (US), The Schwabe Group (Germany), Gaia Herbs Farm (US), Nordic Naturals (US), ProCaps Laboratories, Inc. (US), Sunwarrior LLC (US), Nutrex Hawaii (China), and Navitas Organics (US).
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
